Solid Biosciences, Inc. (SLDB)
10.11
+0.39
(+4.01%)
USD |
NASDAQ |
Aug 27, 12:34
Solid Biosciences Price to Book Value : 2.841 for Aug. 27, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 26, 2026 | 2.732 |
| August 25, 2026 | 2.779 |
| August 24, 2026 | 2.574 |
| August 21, 2026 | 2.614 |
| August 20, 2026 | 2.557 |
| August 19, 2026 | 2.737 |
| August 18, 2026 | 2.552 |
| August 17, 2026 | 2.557 |
| August 14, 2026 | 2.586 |
| August 13, 2026 | 2.552 |
| August 12, 2026 | 2.548 |
| August 11, 2026 | 2.487 |
| August 10, 2026 | 2.406 |
| August 07, 2026 | 2.358 |
| August 06, 2026 | 2.448 |
| August 05, 2026 | 2.453 |
| August 04, 2026 | 2.422 |
| August 03, 2026 | 2.254 |
| July 31, 2026 | 2.265 |
| July 30, 2026 | 2.386 |
| July 29, 2026 | 2.260 |
| July 28, 2026 | 2.240 |
| July 27, 2026 | 2.217 |
| July 24, 2026 | 2.200 |
| July 23, 2026 | 2.243 |
| Date | Value |
|---|---|
| July 22, 2026 | 2.276 |
| July 21, 2026 | 2.378 |
| July 20, 2026 | 2.375 |
| July 17, 2026 | 2.451 |
| July 16, 2026 | 2.543 |
| July 15, 2026 | 2.704 |
| July 14, 2026 | 2.706 |
| July 13, 2026 | 2.732 |
| July 10, 2026 | 2.928 |
| July 09, 2026 | 3.131 |
| July 08, 2026 | 3.091 |
| July 07, 2026 | 3.134 |
| July 06, 2026 | 3.111 |
| July 02, 2026 | 3.046 |
| July 01, 2026 | 2.866 |
| June 30, 2026 | 2.808 |
| June 29, 2026 | 2.491 |
| June 26, 2026 | 2.443 |
| June 25, 2026 | 2.330 |
| June 24, 2026 | 2.433 |
| June 23, 2026 | 2.312 |
| June 22, 2026 | 2.183 |
| June 18, 2026 | 2.191 |
| June 17, 2026 | 1.922 |
| June 16, 2026 | 1.859 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.35 |
| Anika Therapeutics, Inc. | 2.081 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.804 |
Price to Book Value Related Metrics
| Price | 10.11 |
| Earnings Yield | -18.88% |
| Market Cap | 1.063B |